Trial
NCT00235495
Albumin in Acute Ischemic Stroke Trial
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); University of Calgary; Medical University of South Carolina; Neurological Emergencies Treatment Trials Network (NETT)
Condition
Ischemic Stroke
Intervention
Albumin
Why stopped
Recruitment halted by DSMB following interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-17